Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment
about
CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritisRADB: a database of rheumatoid arthritis-related polymorphisms.Lack of association of variants previously associated with anti-TNF medication response in rheumatoid arthritis patients: results from a homogeneous Greek populationCurrent and future trends in biomarker discovery and development of companion diagnostics for arthritis.Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's DiseaseCorrelation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study SCD226 rs763361 (Gly307Ser) polymorphism is associated with susceptibility to rheumatoid arthritis in Zahedan, southeast IranHow genetic variation affects patient response and outcome to therapy for psoriasis.Genetic and genomic predictors of anti-TNF response.Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy.Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.Association of PTPN22 Gene Polymorphisms with Susceptibility to Juvenile Idiopathic Arthritis in Iranian Population.IL2/IL21 region polymorphism influences response to rituximab in systemic lupus erythematosus patients.Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.Genomewide association studies for hematological traits and T lymphocyte subpopulations in a Duroc × Erhualian F resource population.Association of rheumatoid arthritis risk alleles with response to anti-TNF biologics: results from the CORRONA registry and meta-analysis.Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritis.
P2860
Q28728734-2D359689-7284-41E3-A247-B092350F1C9FQ34185466-2FE2BA7B-7578-4229-92F2-D313F4CA75A7Q34989977-E63CE1C9-E4EA-4C52-8F7A-F32BA1A33676Q35470652-8605478A-2A9F-444E-9C8F-09A3D920743FQ36189976-3A30CDFB-2099-41A6-A016-29B94DEAA89AQ36237186-EDEF2062-C336-4A46-AC14-DBAA833BB1E9Q36633196-89BBB07E-B0C6-4524-9A6B-EA37A32961CDQ37441905-D4F1F930-1B08-4FF6-9486-E028578B8B34Q37803415-144D6F72-C372-40DD-B313-1D68F0FFC428Q37951648-94BE4E89-FD30-441C-9373-E1D2956F898FQ38084444-65CD2A89-1340-41CA-9F03-29B7D70A2FA3Q38258624-CBB2D1C2-2299-4CC4-B7B1-CA65843ED2F6Q38728689-9882EB25-D0CB-4A44-B8D2-C130E9052F9FQ40509418-19C9B17D-049B-4C4E-8AE3-1D4BACADC1EDQ43693855-3148D5E7-8754-483F-8B8F-2E001A122032Q48198050-37DAB4DA-22C5-40A9-8F72-200DCCFC64FAQ48644239-30000B74-4474-46AA-9DC8-8AD19BC27744Q53123281-28CCED63-59B2-42D0-B09C-51E1E57B974FQ54595969-982792DB-1FB6-46CF-92C2-0BA5DE53F5BE
P2860
Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@ast
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@en
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@en-gb
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@nl
type
label
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@ast
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@en
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@en-gb
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@nl
prefLabel
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@ast
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@en
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@en-gb
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@nl
P2093
P2860
P921
P356
P1476
Investigation of rheumatoid ar ...... mour necrosis factor treatment
@en
P2093
Ann W Morgan
Anthony G Wilson
Catherine Potter
Kimme L Hyrich
Laura J Gibbons
Rachael J L Tan
P2860
P304
P356
10.1136/ARD.2009.118406
P407
P577
2010-06-01T00:00:00Z